870487-04-0 (Fmoc-Cit-PAB-OH,Fmoc-Cit-PAB-OH)

CAS号:
870487-04-0
中文名称:
Fmoc-Cit-PAB-OH
英文名称:
Fmoc-Cit-PAB-OH
分子式:
C28H30N4O5
分子量:
502.561606884003

Fmoc-Cit-PAB-OH(870487-04-0)名称与标识符

名称

中文别名:
Nα-Fmoc-L-瓜氨酸(4-羟甲基)苯基酰胺;[1-[[4-(羟基甲基)苯基]氨基]-1-氧代-5-脲基戊烷-2-基]氨基甲酸(S)-(9H-芴-9-基)甲酯;
英文别名:
(S)-(9H-Fluoren-9-yl)methyl [1-[[4-(Hydroxymethyl)phenyl]amino]-1-oxo-5-ureidopentan-2-yl]carbamate;Nα-Fmoc-L-citrulline (4-Hydroxymethyl)phenylamide;Fmoc-Cit-PAB-OH;(9H-Fluoren-9-yl)methyl (S)-(1-((4-(hydroxymethyl)phenyl)amino)-1-oxo-5-ureidopentan-2-yl)carbamate;9H-fluoren-9-ylmethyl N-[(2S)-5-(carbamoylamino)-1-[4-(hydroxymethyl)anilino]-1-oxopentan-2-yl]carbamate;9H-Fluoren-9-ylmethyl N-[(1S)-4-[(aminocarbonyl)amino]-1-[[[4-(hydroxymethyl)phenyl]amino]carbonyl]butyl]carbamate (ACI);Carbamic acid, [(1S)-4-[(aminocarbonyl)amino]-1-[[[4-(hydroxymethyl)phenyl]amino]carbonyl]butyl]-, 9H-fluoren-9-ylmethyl ester (9CI);

标识符

MDL:
MFCD32062910
InChIKey:
KBTCNJJDJZRXCX-VWLOTQADSA-N
Inchi:
1S/C28H30N4O5/c29-27(35)30-15-5-10-25(26(34)31-19-13-11-18(16-33)12-14-19)32-28(36)37-17-24-22-8-3-1-6-20(22)21-7-2-4-9-23(21)24/h1-4,6-9,11-14,24-25,33H,5,10,15-17H2,(H,31,34)(H,32,36)(H3,29,30,35)/t25-/m0/s1
SMILES:
O(C(N[C@H](C(NC1C=CC(CO)=CC=1)=O)CCCNC(N)=O)=O)CC1C2C=CC=CC=2C2=CC=CC=C12

Fmoc-Cit-PAB-OH(870487-04-0)物化性质

计算特性

  • 氢键供体数量 : 5
  • 氢键受体数量 : 5
  • 可旋转化学键数量 : 11
  • 重原子数量 : 37
  • 复杂度 : 750
  • 疏水参数计算参考值(XlogP) : 2.6
  • 拓扑分子极性表面积 : 143

Fmoc-Cit-PAB-OH(870487-04-0)安全信息

Fmoc-Cit-PAB-OH(870487-04-0)合成路线

合成路线:1 步
反应条件:
参考文献:
The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-targeted drug conjugates
Klahn, Philipp; et al, Chemical Science, 2019, 10(20), 5197-5210
合成路线:2 步
反应条件:
参考文献:
Improved methodology for the synthesis of a cathepsin b cleavable dipeptide linker, widely used in antibody-drug conjugate research
Mondal, Deboprosad; et al, Tetrahedron Letters, 2018, 59(40), 3594-3599

Fmoc-Cit-PAB-OH(870487-04-0)参考资料

Reaxys RN:
14479302